Dyadic International to present at H.C. Wainwright and BioProcess International conferences.
ByAinvest
Thursday, Sep 4, 2025 9:07 am ET1min read
DYAI--
Hazelton will be speaking at the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8-10, 2025. The webcast link for Dyadic's investor presentation will be available on their website. Additionally, Dyadic will be represented at the BioProcess International BPI East conference, taking place from September 15-18, 2025, and the Sidoti Small Cap Investor Event, which runs from September 17-18, 2025.
Dyadic Applied BioSolutions leverages proprietary microbial platforms to produce recombinant proteins for various markets, including life sciences, food and nutrition, and bio-industrial applications. The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing and are integral to its growing portfolio of commercial and partnered programs.
The management team welcomes the opportunity to connect with attendees at these conferences and has made it easy to request a meeting by reaching out to jlavalley@dyadic.com.
For more information about Dyadic, visit www.dyadic.com.
References:
[1] https://www.marketscreener.com/news/dyadic-to-present-at-investor-conferences-and-bpi-east-ce7d59d8db8cf22d
[2] https://www.morningstar.com/news/globe-newswire/9522610/dyadic-to-present-at-investor-conferences-and-bpi-east
Dyadic International, a biotechnology company focused on scalable production of high-value proteins, announced that Joe Hazelton, its President & Chief Operating Officer, will attend and present at the H.C. Wainwright 27th Annual Global Investment Conference, BioProcess International BPI East, and Sidoti Small Cap Investor Event. Dyadic's management team welcomes the opportunity to connect with investors, analysts, and industry partners during the conferences.
Jupiter, Fla., September 02, 2025 — Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (Nasdaq: DYAI), a global biotechnology company specializing in the scalable production of high-value, precision-engineered functional input proteins, has announced that Joe Hazelton, its President & Chief Operating Officer, will attend and present at several upcoming investor conferences. The company aims to engage with investors, analysts, and industry partners during these events.Hazelton will be speaking at the H.C. Wainwright 27th Annual Global Investment Conference, scheduled for September 8-10, 2025. The webcast link for Dyadic's investor presentation will be available on their website. Additionally, Dyadic will be represented at the BioProcess International BPI East conference, taking place from September 15-18, 2025, and the Sidoti Small Cap Investor Event, which runs from September 17-18, 2025.
Dyadic Applied BioSolutions leverages proprietary microbial platforms to produce recombinant proteins for various markets, including life sciences, food and nutrition, and bio-industrial applications. The company's C1 and Dapibus™ expression systems support flexible, cost-effective manufacturing and are integral to its growing portfolio of commercial and partnered programs.
The management team welcomes the opportunity to connect with attendees at these conferences and has made it easy to request a meeting by reaching out to jlavalley@dyadic.com.
For more information about Dyadic, visit www.dyadic.com.
References:
[1] https://www.marketscreener.com/news/dyadic-to-present-at-investor-conferences-and-bpi-east-ce7d59d8db8cf22d
[2] https://www.morningstar.com/news/globe-newswire/9522610/dyadic-to-present-at-investor-conferences-and-bpi-east
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet